Want to join the conversation?
$MYL and and Biocon, which have co-developed this proposed biosimilar, expect that this may be first MAA for Trastuzumab biosimilar accepted by EMA for review. This filing includes analytical, functional and pre-clinical data, as well as results from pharmacokinetics (PK) and confirmatory efficacy/safety global clinical trials for Trastuzumab.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.